PRC1 and synovial sarcoma: Since 2020, there have been significant advances in our understanding of the epigenetic mechanisms underlying SS – abnormal methylation and histone modification patterns, and the role of PRC1 and BAF complexes in maintaining the SS oncogenic program (Fig. 2).